Effect of Clofibrate in term neonatal jaundice
Phase 3
- Conditions
- eonatal jaundice.Neonatal jaundice, unspecified
- Registration Number
- IRCT20180610040036N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Term neonates(gestational age more than 38 weeks)
Iranian,Asian race
2-14 day-old
Non-hemolytic icter
Total serum bilirubin(TSB)=13-20 mg/dl
Exclusion Criteria
Hemolytic icter
Total serum bilirubin(TSB) >20 mg/dl
Sepsis
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total serum bilirubin level. Timepoint: Total serum bilirubin level before intervention then 6,12,24,48,72 hours after intervention. Method of measurement: Mindray BS-200 analyzer.
- Secondary Outcome Measures
Name Time Method Cholesterol. Timepoint: At bedtime before intervention , 72 hours after intervention. Method of measurement: Mindray BS-200 analyzer.;Triglycerides. Timepoint: At bedtime before intervention , 72 hours after intervention. Method of measurement: Mindray BS-200 analyzer.